Class: | Sympathomimetic |
Cas Number: | 15686-81-4 |
Cas Supplemental: | 13329-35-6 (hydrochloride) |
Pubchem: | 166575 |
Chemspiderid: | 145768 |
Unii: | 8P6T83567P |
Chembl: | 2106796 |
Synonyms: | Norbutrine; RD-9338; N-Cyclobutylnoradrenaline; N-Cyclobutylnorepinephrine |
Iupac Name: | 4-[2-(cyclobutylamino)-1-hydroxyethyl]benzene-1,2-diol |
C: | 12 |
H: | 17 |
N: | 1 |
O: | 3 |
Smiles: | C1CC(C1)NCC(C2=CC(=C(C=C2)O)O)O |
Stdinchi: | 1S/C12H17NO3/c14-10-5-4-8(6-11(10)15)12(16)7-13-9-2-1-3-9/h4-6,9,12-16H,1-3,7H2 |
Stdinchikey: | OVTZNVCECJYMDW-UHFFFAOYSA-N |
Norbudrine (; developmental code name RD-9338), also known as norbutrine or as N-cyclobutylnoradrenaline, is a drug of the phenethylamine and catecholamine families described as a sympathomimetic and bronchodilator which was never marketed.[1] [2] [3] It is the N-cyclobutyl analogue of norepinephrine (noradrenaline).[4] The drug was first described in the literature by 1966.